Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Rheumatology (Oxford, England)|October 31, 2021
Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and AurumGeorgina Nakafero, Matthew J Grainge, Tim Card, et al.
Public Health|July 6, 2025
Patients with non-White ethnicity and from poorer social classes are sicker at initial presentation to hospital with COVID-19 infectionColin J Crooks, Joe West, Tasso Gazis, et al.
RMD Open|March 7, 2024
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validationAbhishek Abhishek, Matthew Grainge, Tim Card, et al.
Gastrointestinal Endoscopy|January 26, 2020
Use of rapid reading software to reduce capsule endoscopy reading times while maintaining accuracySabina Beg, Ewa Wronska, Isis Araujo, et al.
Rheumatology Advances in Practice|June 15, 2022
Incidence and pattern of mycophenolate discontinuation associated with abnormal monitoring blood-test results: cohort study using data from the Clinical Practice Research Datalink AurumGeorgina Nakafero, Matthew J Grainge, Tim Card, et al.
Rheumatology (Oxford, England)|March 14, 2024
Patient and health professional views on risk-stratified monitoring of immune-suppressing treatment in adults with inflammatory diseasesAmy Fuller, Jennie Hancox, Hywel C Williams, et al.
Eclinicalmedicine|September 25, 2023
Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: prognostic model development, validation, and, health economic evaluationGeorgina Nakafero, Tim Card, Matthew J Grainge, et al.
BMJ (Clinical Research Ed.)|May 30, 2023
Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UKGeorgina Nakafero, Matthew J Grainge, Hywel C Williams, et al.
The British Journal of Dermatology|November 6, 2023
Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategiesAbhishek Abhishek, Matthew D Stevenson, Georgina Nakafero, et al.
Pageof 4